tiprankstipranks
Sierra Oncology (SRRA)
NASDAQ:SRRA

Sierra Oncology (SRRA) Financial Statements

0 Followers

Sierra Oncology Financial Overview

Sierra Oncology's market cap is currently ―. The company's EPS TTM is $-6.764; its P/E ratio is -8.13; Sierra Oncology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 22Dec 21Sep 21Jun 21Mar 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -27.88M$ -25.59M$ -28.60M$ -20.57M$ -19.82M
EBITDA$ -27.79M$ -25.50M$ -28.51M$ -20.50M$ -19.77M
Net Income Common Stockholders$ -27.93M$ -25.47M$ -28.65M$ -20.63M$ -19.91M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 90.69M$ 97.07M$ 104.06M$ 104.75M$ 107.66M
Total Assets$ 280.00M$ 109.37M$ 104.23M$ 94.38M$ 110.56M
Total Debt$ 315.00K$ 382.00K$ 431.00K$ 803.00K$ 899.00K
Net Debt$ -90.38M$ -96.69M$ -103.62M$ -103.95M$ -106.76M
Total Liabilities$ 18.38M$ 13.37M$ 9.17M$ 10.11M$ 9.01M
Stockholders Equity$ 84.27M$ 95.06M$ 96.00M$ 97.96M$ 101.56M
Cash Flow-
Free Cash Flow$ -25.80M$ -15.28M$ -29.75M$ -17.05M$ -16.96M
Operating Cash Flow$ -25.74M$ -15.25M$ -29.75M$ -17.00M$ -16.96M
Investing Cash Flow$ -62.00K$ -32.00K$ 0.00$ -40.00K$ 0.00
Financing Cash Flow$ 195.06M$ 22.96M$ 36.16M$ 113.00K$ 20.58M
Currency in USD

Sierra Oncology Earnings and Revenue History

Sierra Oncology Debt to Assets

Sierra Oncology Cash Flow

Sierra Oncology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis